SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-172585
Filing Date
2023-06-22
Accepted
2023-06-22 16:30:58
Documents
12
Period of Report
2023-06-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d512906d8k.htm   iXBRL 8-K 26316
  Complete submission text file 0001193125-23-172585.txt   151740

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnov-20230615.xsd EX-101.SCH 2860
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20230615_lab.xml EX-101.LAB 18758
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20230615_pre.xml EX-101.PRE 11717
6 EXTRACTED XBRL INSTANCE DOCUMENT d512906d8k_htm.xml XML 3562
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 231033707
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences